This page was last updated on 3/9/2023. Please check back frequently for updates.
The American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry (ASCO Registry) collects data about patients undergoing cancer treatment who have a confirmed prior or current COVID-19 infection. Specifically, the registry collects data about patients with cancer and patients who are cancer-free receiving adjuvant cancer therapy within a year of cancer surgery, including patients receiving hormone-only adjuvant therapy and patients receiving supportive care only. The ASCO Registry is designed to collect both baseline and follow-up data on how the virus impacts cancer care and cancer patient outcomes during the COVID-19 pandemic and into 2022. The Registry is closed to new practices/patients; however, we are continuing to collect follow-up data on current patients.
ASCO provides deidentified ASCO Registry data for research purposes to qualified individuals and organizations. Information on the process to submit a proposed research study is available at the Data Library link below.
View the COVID-19 Data Dashboard View the COVID-19 Registry Data Map
Request the COVID-19 Registry Data in ASCO’s Data Library
Study Information
ASCO Publications
- Manuscript: Dr. Dax Kurbegov, et al., Rate of COVID‐19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome‐coronavirus 2: Analysis of the American Society of Clinical Oncology Registry - Kurbegov - Cancer - Wiley Online Library
- Abstract: Breakthrough COVID-19 cases and hospitalization risk: ASCO COVID-19 registry. | Journal of Clinical Oncology (ascopubs.org)
- Abstract: COVID-19 vaccine uptake in patients with cancer and Sars-Cov-2 infection in 2020: Results from the ASCO registry. | Journal of Clinical Oncology (ascopubs.org)
- Manuscript: Dr. Kathryn F. Mileham et al., Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry | JCO Oncology Practice (ascopubs.org)
- Abstract: Dr. Kathryn F. Mileham et al., Mortality risk for patients undergoing cancer treatment who acquire SARS-CoV-2: ASCO registry. | Journal of Clinical Oncology (ascopubs.org)
ASCO Research Grants
- Conquer Cancer names inaugural recipients of ASCO Registry Research Grants
- ASCO Registry Melanoma Research Grant
Grantee Publications
- Manuscript: Dr. Adana A.M. Llanos et al., Evaluation of Inequities in Cancer Treatment Delay or Discontinuation Following SARS-CoV-2 Infection
- Manuscript: Dr. Samyukta Mullangi et al., Reexamining Social Determinants of Health Data Collection in the COVID-19 Era
- Manuscript: Dr. Samyukta Mullangi et al., Factors Associated With Cancer Treatment Delay Among Patients Diagnosed With COVID-19
- Abstract: Dr. Jessica Y. Islam et al., Racial/ethnic disparities of cancer treatment disruptions among patients with breast cancer with SARS-CoV-2 infection: An analysis of the ASCO Survey on COVID-19 in Oncology Registry. | Journal of Clinical Oncology (ascopubs.org)
- Abstract: Dr. Jessica Y. Islam et al., The role of rurality in cancer treatment disruptions among patients with cancer diagnosed with SARS-CoV-2: An analysis of the ASCO Survey on COVID-19 in Oncology Registry. | Journal of Clinical Oncology (ascopubs.org)
- Abstract: Dr. Jessica Y. Islam et al., Disparities in cancer treatment delays or discontinuation among cancer patients diagnosed with SARS-CoV-2 infection: An analysis of the U.S. ASCO COVID-19 and cancer registry | Cancer Research | American Association for Cancer Research (aacrjournals.org)
Please contact the CENTRA team for additional information or questions.